ロード中...
Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study
BACKGROUND: Tetrabenazine (TBZ) is commonly used in hyperkinetic movement disorders. In this retrospective study, we aimed to assess the TBZ effectiveness and adverse events (AEs) in Huntington disease (HD), vascular chorea, tics, dystonia, tardive oromandibular (OM) dyskinesia and other tardive syn...
保存先:
| 出版年: | Ther Adv Neurol Disord |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5367646/ https://ncbi.nlm.nih.gov/pubmed/28382107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616677004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|